Monjuvi added to Rituxan and Revlimid extended progression-free survival from 14 to 22 months in follicular lymphoma, ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

A local cancer survivor, Robert Dames, has released a new book titled "Cancer - What Now" to assist others in navigating the ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...

The Central Texas Cancer Survivor Party, part of Cattle Baron’s Ball, will be held at 5:30 p.m. July 22 at the Texas Sports ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

As a graphic design artist, she now works for the fundraising arm ... Adrienne has actually been a part of St. Jude Life, a research study that brings long-term childhood cancer survivors back to St.